Albendazole, marketed as Albenza among others, is medication used for the treatment of a variety of parasitic worm infestations. It is useful for giardiasis, trichuriasis, filariasis, neurocysticercosis, hydatid disease, pinworm disease, and ascariasis, among others. It is taken by mouth.[2]
Starting at
Methyl [5-(propylthio)-1H-benzoimidazol-2-yl]carbamate |
Trade names | Albenza |
AHFS/Drugs.com | monograph |
MedlinePlus | a610019 |
Pregnancy category |
AU: D US: C (Risk not ruled out) |
Legal status |
AU: S4 (Prescription only) CA: ℞-only UK: POM (Prescription only) US: ℞-only |
Routes of administration |
Oral |
Bioavailability | <5%[1] |
Protein binding | 70%[1] |
Metabolism | Hepatic[1] |
Biological half-life | 8-12 hours[1] |
Excretion | Urine, faeces[1] |
CAS Number | 54965-21-8 |
ATC code | P02CA03 QP52AC11 |
PubChem | CID: 2082 |
DrugBank | DB00518 |
ChemSpider | 1998 |
UNII | F4216019LN |
KEGG | D00134 |
ChEBI | CHEBI:16664 |
ChEMBL | CHEMBL1483 |
NIAID ChemDB | 007895 |
Formula | C12H15N3O2S |
Molecular mass | 265.333 g/mol |
SMILES[show] |
|
InChI[show] |
Melting point | 208 to 210 °C (406 to 410 °F) |